Tygh Capital Management, Inc. - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 181 filers reported holding PTC THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.85 and the average weighting 0.7%.

Quarter-by-quarter ownership
Tygh Capital Management, Inc. ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$1,847,000
+6.8%
46,372
-0.2%
0.24%
+0.9%
Q3 2021$1,729,000
+6.9%
46,472
+21.4%
0.23%
+6.4%
Q2 2021$1,618,000
-11.6%
38,283
-1.0%
0.22%
-15.1%
Q1 2021$1,831,000
-19.2%
38,679
+4.1%
0.26%
-26.6%
Q4 2020$2,267,000
+31.8%
37,140
+0.9%
0.35%
+8.3%
Q3 2020$1,720,00036,7920.33%
Other shareholders
PTC THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,235,196$162,140,7423.42%
Camber Capital Management LP 3,400,000$76,1942.51%
ARMISTICE CAPITAL, LLC 6,150,000$137,821,5002.11%
GREAT POINT PARTNERS LLC 500,000$11,205,0002.04%
COWEN AND COMPANY, LLC 799,511$17,917,0411.25%
GEORGE KAISER FAMILY FOUNDATION 45,816$6,491,2111.22%
SPHERA FUNDS MANAGEMENT LTD. 218,459$4,895,6660.89%
SECTORAL ASSET MANAGEMENT INC 187,016$4,191,0290.82%
Nebula Research & Development LLC 21,858$489,8380.26%
Phocas Financial Corp. 64,701$1,450,0000.21%
View complete list of PTC THERAPEUTICS INC shareholders